- Mustang research partner City of Hope awarded California Institute for Regenerative Medicine grant to support ongoing Phase 1 study NEW YORK, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang) (NASDAQ:MBIO), a Fortress Biotech, Inc. (NASDAQ:
Original Article: Mustang Bio Announces $12.8 Million Grant To Fund Phase I Trial Of CAR T Therapy MB-101 In Malignant Glioma
NEXT ARTICLE